Waldenstrom macroglobulinemia: A review of therapy

被引：13
|
作者：
Gertz, MA [1 ]
机构：
[1] Mayo Clin, Div Hematol & Internal Med, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2005年 / 79卷 / 02期
关键词：
hyperviscosity syndrome; lymphoplasmacytic lymphoma; monoclonal antibody therapy; monoclonal gammopathy; Waldenstrom macroglobulinemia;
D O I：
10.1002/ajh.20363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Waldenstrom macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenstrom macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码：147 / 157
页数：11
相关论文
共 50 条
  • [1] Waldenstrom's macroglobulinemia: A review of therapy
    Gertz, MA
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1517 - 1526
  • [2] Tailoring Therapy in Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S59 - S60
  • [3] Waldenstrom's macroglobulinemia: a review
    Coimbra, Susana
    Neves, Rafael
    Lima, Margarida
    Belo, Luis
    Santos-Silva, Alice
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2014, 60 (05): : 490 - 499
  • [4] Androgenic therapy for Waldenstrom's macroglobulinemia
    Porrata, Luis F.
    Markovic, Svetomir N.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (11) : 892 - 893
  • [5] Fludarabine therapy in Waldenstrom's macroglobulinemia
    Thalhammer-Scherrer, R
    Geissler, K
    Schwarzinger, I
    Chott, A
    Gisslinger, H
    Knöbl, P
    Lechner, K
    Jäger, U
    [J]. ANNALS OF HEMATOLOGY, 2000, 79 (10) : 556 - 559
  • [6] Waldenstrom Macroglobulinemia: Tailoring Therapy for the Individual
    Gertz, Morie A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2600 - +
  • [7] Waldenstrom macroglobulinemia: biology, genetics, and therapy
    Paludo, Jonas
    Ansell, Stephen M.
    [J]. BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2016, 6 : 49 - 58
  • [8] Choice of Therapy for Patients With Waldenstrom Macroglobulinemia
    Ghobrial, Irene M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 291 - 293
  • [9] Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenstrom Macroglobulinemia
    Munoz, Javier
    Paludo, Jonas
    Sarosiek, Shayna
    Castillo, Jorge J.
    [J]. CELLS, 2022, 11 (20)
  • [10] Waldenstrom Macroglobulinemia: Review of Pathogenesis and Management
    Yun, Seongseok
    Johnson, Ariel C.
    Okolo, Onyemaechi N.
    Arnold, Stacy J.
    McBride, Ali
    Zhang, Ling
    Baz, Rachid C.
    Anwer, Faiz
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (05): : 252 - 262
12345